BioSante Pharmaceuticals, Inc.

Type: Public
On the web: http://www.biosantepharma.com
Employees: 8
Employee growth: (42.9%)

BioSante Pharmaceuticals wants to be the patron saint of hormonal ups and downs. The firm is developing topical hormone therapy gels to deliver supplemental estradiol, progestogen, or testosterone. Lead product Elestrin has received its FDA approval to treat menopausal symptoms in women. The company's other product candidates still in development include gels that treat female sexual dysfunction (LibiGel) and testosterone deficiency in men (Bio-T-Gel). BioSante has licensed to Solvay Pharmaceuticals its Bio-E/P-Gel, a combination of estrogen and progestogen to help menopausal women.

Key numbers for fiscal year ending December, 2007:
Sales: $0.5M
One year growth: (96.6%)
Net income: ($7.6)M

Officers:
Chairman: Louis W. Sullivan
Vice Chairman, President, and CEO: Stephen M. Simes
CFO, Treasurer, and Secretary: Phillip B. Donenberg

Competitors:
GlaxoSmithKline
Noven Pharmaceuticals
VIVUS

BPA might be an acronym or abbreviation for:

• Bisphenol A
• British Parachute Association
• British Pyrotechnists Association
• Bradford Park Avenue F.C.
• Bloodstain pattern analysis
• Boardgame Players Association
• Bonneville Power Administration
• Bradford Park Avenue
• Business of Performing Audits
• British Pipeline Agency
• Business Process Automation
• Business Professionals of America
• Boricua Popular Army
• Bush Pilot Airways

This disambiguation page lists articles associated with the same title. If an internal link led you here, you may wish to change the link to point directly to the intended article.

This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)